Literature DB >> 15142523

Autoimmunity through cytokine-induced dendritic cell activation.

Jacques Banchereau1, Virginia Pascual, A Karolina Palucka.   

Abstract

We propose a model where autoimmunity can be viewed as a dynamic system driven by opposite vectors IFN-alpha/beta and TNF. These cytokines drive differentiation of distinct types of DCs, TNF-DCs, or IFN-DCs, which present different antigens leading to distinct autoimmune responses. When balanced, both cytokines synergize in protective immunity. When one of the cytokines prevails, autoimmunity occurs, Type I interferons (IFN-alpha/beta) playing a major role in systemic lupus erythematosus (SLE) and TNF playing a major role in rheumatoid arthritis. This model complements the Type 1/Type 2 paradigm. Therefore, immunity can be viewed as a dynamic system driven by two sets of opposite vectors: IFN-alpha/beta/TNF and IFN-gamma/IL-4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142523     DOI: 10.1016/s1074-7613(04)00108-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  94 in total

1.  Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset.

Authors:  Uma Sriram; Linda Varghese; Heather L Bennett; Neelakshi R Jog; Debra K Shivers; Yue Ning; Edward M Behrens; Roberto Caricchio; Stefania Gallucci
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

3.  Dendritic cells continue to capture and present antigens after maturation in vivo.

Authors:  Scott B Drutman; E Sergio Trombetta
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

4.  Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.

Authors:  Guy Shakhar; Randall L Lindquist; Dimitris Skokos; Diana Dudziak; Julie H Huang; Michel C Nussenzweig; Michael L Dustin
Journal:  Nat Immunol       Date:  2005-05-29       Impact factor: 25.606

Review 5.  Human dendritic cell subsets for vaccination.

Authors:  Peter Dubsky; Hideki Ueno; Bernard Piqueras; John Connolly; Jacques Banchereau; A Karolina Palucka
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

6.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.

Authors:  Kevin Evel-Kabler; Xiao-Tong Song; Melissa Aldrich; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

7.  Regulation of the lifespan in dendritic cell subsets.

Authors:  Min Chen; Li Huang; Zainuer Shabier; Jin Wang
Journal:  Mol Immunol       Date:  2007-01-30       Impact factor: 4.407

8.  Jacques Banchereau, PHD: a conversation with Michael Ramsay, MD, president of Baylor Research Institute.

Authors:  Jacques Banchereau; Michael A E Ramsay
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-10

9.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

10.  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine.

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Stella Douma; Areti Triantafyllou
Journal:  Clin Rheumatol       Date:  2007-11-10       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.